Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Stabilized enzymes or enzymes complexed with nonenzyme
Patent
1995-06-06
1998-06-02
Witz, Jean C.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Stabilized enzymes or enzymes complexed with nonenzyme
424 942, 424 944, A61K 3844
Patent
active
057595399
ABSTRACT:
A method and formulations have been developed to accelerate ethanol elimination from the body, which combine enzymes that oxidize alcohol to acetate, enzymes which regenerate NADH to NAD, substrates which are rate limiting for the requisite enzymes, buffering agents which protect the enzymes against pH variations (e.g. low gastric pH), gastric acid sequestrants which block synthesis of gastric acid, protease inhibiting agents and other agents which protect the enzymes against proteolysis, carbohydrates which protect labile enzymes against bile salt inactivation, and a source of oxygen for efficient catalysis by some of the enzymes, with a packaging for delivery of a functional enzyme system to an appropriate in vivo site for ethanol conversion to acetate. The oxygen source can be mechanical means, such as a tube or catheter which directs oxygen from a high pressure source into the upper gastrointestinal tract for the most rapid removal of ethanol from the blood as in the case where a patient has overdosed and is unconscious, a physical carrier of oxygen, for example, oxygen microencapsulated in an appropriate polymeric matrix, or an oxygen generating formulation such as catalase (one to ten million units) with hydrogen peroxide (0.1-200 grams), which is stable to passage through the stomach and releases oxygen in the gastrointestinal tract. The formulation is preferably administered orally, although it can also be packaged for administration in any surface through which rapid transport of ethanol from blood to the enzymes can occur. A preferred surface for rapid ethanol transport is mucosal membrane such as is found in the intestine or mouth.
REFERENCES:
patent: 2730456 (1956-01-01), Green et al.
patent: 2730457 (1956-01-01), Green et al.
patent: 2800457 (1957-07-01), Green et al.
patent: 3625214 (1971-12-01), Higuchi et al.
patent: 4272398 (1981-06-01), Jaffe
patent: 4310554 (1982-01-01), Olson et al.
patent: 4431428 (1984-02-01), Schmer
patent: 4798734 (1989-01-01), Kaneda
patent: 4906474 (1990-03-01), Langer et al.
patent: 4925673 (1990-05-01), Steiner et al.
patent: 5302400 (1994-04-01), Sipos
Whitmire, Dissertation Abstracts International 51(11-B):5453 (1988).
Whitmire et al., Alcoholism: Clinical and Experimental Research 15(5):804-807 (Oct. 1991). Membrane-Bound," Methods in Enzymology 89:450-457 (1982). Membrane-Bound," Methods in Enzymology 89:491 (1982).
Armstrong, et al. Assessement of Myocardial Perfusion Abnormalities with Contrast-enhanced Two-dimensional Echocardiography 66:166-173 (1982).
Benita, et al. "Characterization of Drug-Loaded Ploy(d,-lactide) Microsphers,": J. Pharm Sci. 73: 1721-1724 (1984).
Bostian and Betts, "Rapid Purification and Properties of Potassium-Activated Aldehyde Dehydrogenase from Saccharomyces Cerevisiae," Biochemical Journal, 173: 773-786 (1978).
Buhner, M., and Sund H., "Yeast Alcohol Dehydrogenase:--SH Groups, Disulfide Groups, Quaternary Structure, and Reactivation by Reductive Cleavage of Disulfide Groups," European Journal of Biochemistry 11:73-79 (1969).
*Commander, J. C. M.S. thesis from Auburn University, Alabama, (1980) see also Microencapsulation and Related Drug Processes, pp. 61-193 (Dekker, 1984).
Deasy, Patrick, Microencapsulation and Related Drug Processes, pp. 61-193 (Dekker, 1984).
Feinstein, et al., "Two-Dimensional contrast Echocardiography. I. In Vitro Development and Quantitative Analysis of Echo Contrast Agents," J. Am. Coll. Cardiol 3: 14-20 (1984).
Gillam, et al. "Functional and Pathologic Effects of Multiple Echocardiographic Contrast Injections on the Myocardium, Brian and Kidney," J. Am Coll. Cardiol, 6:687-694 (1985).
Gregoriadis, G. Chapter 14 ("Liposomes") Drug Carriers in Biology and Medicine, pp. 287-341 (Academic Press, 1979).
Ireton-Jones, et al., "Doses the Use of an Enteral Feeding Tube with a pH Sensitive Tip Facilitate Enteral Nutrition?" J. Burn Care Rehabilitation 14(2, pt 1):215-217 (1993).
Jalil and Nixon, "Biodegradable poly(lactic acid)and poly(lactide-co-glycolide)Microcapsules: Problems Associated with Preparative Techniques and Release Properties," J. Microencapsulation 7:297-325 (1990).
Kemper, et al., "Hydrogen Peroxide Contrast Echocardiography: Quantification in vivo of Myocardial Risk Area During Coronary Occlusion and of the Necrotic Area Remaining After Myocardial Reperfusion," Circulation 70(2):309-317 (1984).
Lim, et al., "Microencapsulation of Living Cells and Tissues," J. Pharm Sci. 70:351-354 (1981).
Edward Majchrowicz Biochemistry and Pharmacology of Ethanol vol. I (Majchrowicz, ed., Plenum Press, N.Y. 2979).
Mathiowitz, et al. "Polyanhydride Microspheres as Drug Carriers. II. Microencapsulation by Solvent Removal," Journal of Applied Polymer Science 35(3):755-774 (1988).
Mathiowitz, et al., "Morphology of Polyanhydride Microsphere Delivery Systems," Scanning Microscopy 4:329-340 (1990).
Metheny, et al., "Effectiveness of pH Measurements in Predicting Feeding Tube Placement," Nursing Research 38(5):280-285 (1989).
Nakano, et al., "Sustained Urinary Excretion of Sulfamethizole Following Oral Administration of Enteric Coated Microcapsules in Humans," Int. J. Pharm. 4:29-298 (1980).
*Salib, et al., Pharmazeutische Industrie 40-11A, 1230 (1978).
Sawhney, et al., "Bioerodible Hydrogels Based on Photopolymerized Poly(ethylene glycol)-co-poly(.alpha.-hydroxy acid) Diacrylate Macromers," Macromolecules 26(No. 4):581-587 (1993).
Sefton, et al., "Ethylene-Vinyl Acetate Copolymer Microsphers for Controlled Release of Macromolecules," J. Pharm. Sci. 73(12):1859-1861 (1984).
Smith, et al., "Superior Intensity and Reproducibility of SHU-454, a New Right Heart Contrast Agent," J. Am Coll. Cardiol 3 (No. 4):992-998 (1984).
*Whitmire, D. R., "Multi Enzyme System with Substrate Pumped NAD Recyling Applied to Ethanol Detoxification of the Dog," Ph.D. dissertation.
Georgia Research Foundation, Inc.
Witz Jean C.
LandOfFree
Method for rapid enzymatic alcohol removal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for rapid enzymatic alcohol removal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for rapid enzymatic alcohol removal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456594